Works in Journal of Nuclear Medicine, 2024, Vol 65, Issue 4
Results: 29
Errata.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 650
- Publication type:
- Article
Advancing Neuroimaging: Julie Price Talks with Henryk Barthel About Enhanced Understanding of the Brain and Neurodegeneration.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 499, doi. 10.2967/jnumed.124.267651
- By:
- Publication type:
- Article
The Accomplishments and Legacy of Saul Hertz, MD.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 659, doi. 10.2967/jnumed.124.267524
- By:
- Publication type:
- Article
First-in-Human <sup>212</sup>Pb-PSMA--Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 664, doi. 10.2967/jnumed.123.267189
- By:
- Publication type:
- Article
Strong Correlation Between SUV<sub>max</sub> on PSMA PET/CT and Numeric Drop-In γ-Probe Signal for Intraoperative Identification of Prostate Cancer Lesions.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 548, doi. 10.2967/jnumed.123.267075
- By:
- Publication type:
- Article
Deep Semisupervised Transfer Learning for Fully Automated Whole-Body Tumor Quantification and Prognosis of Cancer on PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 643, doi. 10.2967/jnumed.123.267048
- By:
- Publication type:
- Article
Development and Preclinical Evaluation of [<sup>211</sup>At]PSAt-3-Ga: An Inhibitor for Targeted a-Therapy of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 593, doi. 10.2967/jnumed.123.267043
- By:
- Publication type:
- Article
PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 540, doi. 10.2967/jnumed.123.267042
- By:
- Publication type:
- Article
Is <sup>18</sup>F-FDG Metabolic Tumor Volume in Lymphoma Really Happening?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 510, doi. 10.2967/jnumed.123.267022
- By:
- Publication type:
- Article
An <sup>18</sup>F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non--Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 520, doi. 10.2967/jnumed.123.266965
- By:
- Publication type:
- Article
Total-Body PET/CT Applications in Cardiovascular Diseases: A Perspective Document of the SNMMI Cardiovascular Council.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 607, doi. 10.2967/jnumed.123.266858
- By:
- Publication type:
- Article
Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 573, doi. 10.2967/jnumed.123.266817
- By:
- Publication type:
- Article
<sup>68</sup>Ga-FAPI-04 PET/CT in Non--Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 527, doi. 10.2967/jnumed.123.266806
- By:
- Publication type:
- Article
<sup>68</sup>Ga-FAPI PET/CT as an Alternative to <sup>18</sup>F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 512, doi. 10.2967/jnumed.123.266798
- By:
- Publication type:
- Article
The Potential Contribution of Radiopharmaceutical Therapies in Managing Oligometastatic Disease.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 502, doi. 10.2967/jnumed.123.266772
- By:
- Publication type:
- Article
Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 586, doi. 10.2967/jnumed.123.266766
- By:
- Publication type:
- Article
PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non--Small Cell Lung Cancer Treated with Curative Radiotherapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 630, doi. 10.2967/jnumed.123.266749
- By:
- Publication type:
- Article
The Value of <sup>68</sup>Ga-PSMA PET/MRI for Classifying Patients with PI-RADS 3 Lesions on Multiparametric MRI: A Prospective Single-Center Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 555, doi. 10.2967/jnumed.123.266742
- By:
- Publication type:
- Article
Can Internal Carotid Arteries Be Used for Noninvasive Quantification of Brain PET Studies?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 600, doi. 10.2967/jnumed.123.266675
- By:
- Publication type:
- Article
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 560, doi. 10.2967/jnumed.123.266702
- By:
- Publication type:
- Article
The Impact of Baseline PSMA PET/CT Versus CT on Outcomes of <sup>223</sup>Ra Therapy in Metastatic Castration-Resistant Prostate Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 541, doi. 10.2967/jnumed.123.266654
- By:
- Publication type:
- Article
Imaging PARP Upregulation with [<sup>123</sup>I]I-PARPi SPECT/CT in Small Cell Neuroendocrine Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 665, doi. 10.2967/jnumed.123.266348
- By:
- Publication type:
- Article
Clinical Evaluation of Deep Learning for Tumor Delineation on <sup>18</sup>F-FDG PET/CT of Head and Neck Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 623, doi. 10.2967/jnumed.123.266574
- By:
- Publication type:
- Article
Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 580, doi. 10.2967/jnumed.123.266524
- By:
- Publication type:
- Article
[<sup>18</sup>F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 617, doi. 10.2967/jnumed.123.266445
- By:
- Publication type:
- Article
Promising Candidate Prognostic Biomarkers in [<sup>18</sup>F]FDG PET Images: Evaluation in Independent Cohorts of Non--Small Cell Lung Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 635, doi. 10.2967/jnumed.123.266331
- By:
- Publication type:
- Article
Single-Time-Point Renal Dosimetry Using Nonlinear Mixed-Effects Modeling and Population-Based Model Selection in [<sup>177</sup>Lu]Lu-PSMA-617 Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 566, doi. 10.2967/jnumed.123.266268
- By:
- Publication type:
- Article
Efficacy of [<sup>67</sup>Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2--Positive Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 533, doi. 10.2967/jnumed.123.265997
- By:
- Publication type:
- Article
Performance Evaluation of the uMI Panorama PET/CT System in Accordance with the National Electrical Manufacturers Association NU 2-2018 Standard.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 652, doi. 10.2967/jnumed.123.265929
- By:
- Publication type:
- Article